Human spermatozoa anti-proprotein convertase subtilisin/kexin type 4 synthesis using New Zealand rabbit for novel immunocontraception in males.
null Dahrilnull Aulanni'amVivi KeumalaAkhmad MustafaPublished in: Investigative and clinical urology (2019)
The result of this study can be used as a basis to develop new immunocontraceptives targeted towards males. This study shows that antibodies from induction of PCSK4 from spermatozoa may hinder fertilization.
Keyphrases